Gargling with povidone iodine has a short-term inhibitory effect on SARS-Cov-2 in COVID-19 patients

Seikai et al., Journal of Hospital Infection, doi:10.1016/j.jhin.2022.01.001

Seikai et al., Gargling with povidone iodine has a short-term inhibitory effect on SARS-Cov-2 in COVID-19 patients, Journal of Hospital Infection, doi:10.1016/j.jhin.2022.01.001

Jan 2022 Source PDF

Twitter
Facebook

All Studies Meta

Small study of 11 patients showing a rapid short-term decrease of viral load in saliva samples with povidone-iodine.

Important missing comments or errors? Let us know.

Seikai et al., 15 Jan 2022, peer-reviewed, 9 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Povidone-Iod..All

Gargling with povidone iodine has a short-term inhibitory effect on SARS-CoV-2 in patients with COVID-19

Tetsuya Seikai, Ayato Takada, Akira Hasebe, Masahiro Kajihara, Kosuke Okuya, T Sekiguchi (yamada), Wataru Kakuguchi, Satoshi Konno, Y Ohiro

Journal of Hospital Infection, doi:10.1016/j.jhin.2022.01.001

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflicts of Interest None declared.

References

Anderson, Sivalingam, Kang, Ananthanarayanan, Arumugam et al., Povidone-iodine demonstrates rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease, Infect Dis Ther

Bidra, Pelletier, Westover, Frank, Brown et al., Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Sasaki, Uemura, Sato, Toba, Sanaki et al., SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells, PLoS Pathog

Shet, Hong, Igo, Cataldo, Bhaskar, In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses, Infect Dis Ther

Late treatment
is less effective

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit